MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Net Income
-$45,546,000
EPS
-$0.98
Unit: Dollar
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Income Statement
2026-06-30
2025-06-30
Royalties and license fees
-
0
Research and development
23,388,000
18,332,000
General and administrative
27,804,000
23,433,000
Total operating expenses
51,192,000
41,765,000
Loss from operations
-51,192,000
-41,765,000
Foreign currency transaction gain (loss)
120,000
-71,000
Interest income, net
5,569,000
3,286,000
Other expense, net
-43,000
-131,000
Gain on extinguishment of liabilities
0
764,000
Unrealized loss on investment
-
0
Total other income, net
5,646,000
3,848,000
Net loss
-45,546,000
-37,917,000
Net loss attributable to common shareholders
-45,546,000
-
Basic EPS
-0.98
-1.05
Diluted EPS
-0.98
-1.05
Basic Average Shares
46,558,162
36,209,271
Diluted Average Shares
46,558,162
36,209,271
Page 1
Unit: Dollar.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
BNTC Income Statement Sankey Diagram
Sankey diagram visualizing BNTC income statement for the period
Net loss
attributable to common...
-$45,546,000
Interest income, net
$5,569,000
(69.48%↑ Y/Y)
Foreign currency
transaction gain (loss)
$120,000
(269.01%↑ Y/Y)
Net loss
-$45,546,000
(-20.12%↓ Y/Y)
Total other income,
net
$5,646,000
(46.73%↑ Y/Y)
Other expense, net
-$43,000
(67.18%↑ Y/Y)
Loss from operations
-$51,192,000
(-22.57%↓ Y/Y)
Total operating
expenses
$51,192,000
(22.57%↑ Y/Y)
General and
administrative
$27,804,000
(18.65%↑ Y/Y)
Research and development
$23,388,000
(27.58%↑ Y/Y)
Buy us a coffee
Benitec Biopharma Inc. (BNTC)
Benitec Biopharma Inc. (BNTC)